Increased Recall of Negative Memories Following Initial Methylphenidate Administration in a 6-Year-Old Boy With ADHD: A Case Report. [PDF]
Neuropsychopharmacol RepAn initial dose of 18 mg of Methylphenidate Hydrochloride Extended‐Release Tablets led to increased recall of negative life events in a 6‐year‐old child with ADHD. The increased recall of negative life events represents a time‐limited symptom rather than a persistent phenomenon.
Xiang Q +5 more
europepmc +2 more sources
Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000-24: analysis of NCIS data. [PDF]
Med J AustMedical Journal of Australia, Volume 222, Issue 5, Page 259-261, March 2025.
Darke S +4 more
europepmc +2 more sources
Methylphenidate and stuttering [PDF]
British Journal of Clinical Pharmacology, 2019 Methylphenidate (MPH) is a piperidine similar to amphetamines, and is indicated for attention deficit hyperactivity disorder. Studies concerning stuttering occurring with MPH are contradictory. We investigated the association between MPH and stuttering. We analysed reports in the World Health Organization global individual case safety reports database,
Thierry Trenque +8 more
openaire +4 more sources
Methylphenidate and pregnancy [PDF]
British Journal of Clinical Pharmacology, 2014 I appreciate the paper by Bolea-Alamanac et al. 1 on the use of methylphenidate in pregnancy and lactation. I would like to point the interested reader towards another recent review on this subject 2. We documented at least 180 first trimester exposed cases (excluding case stories and the case series referred to by Bolea-Alamanac et al.
openaire +4 more sources
Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder [PDF]
, 2015 Past research with the spontaneously hypertensive rat (SHR) model of attention deficit/hyperactivity disorder showed that adolescent methylphenidate treatment enhanced cocaine abuse risk in SHR during adulthood.
Baskin, Britahny M. +2 more
core +1 more source
Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD [PDF]
, 2016 Impulsivity and hyperactivity are two facets of attention deficit/hyperactivity disorder (ADHD). Impulsivity is expressed as reduced response inhibition capacity, an executive control mechanism that prevents premature execution of an intermittently ...
Bardo, M. T. +3 more
core +1 more source
An examination of the effects of stimulant medication on response inhibition: A comparison between children with and without attention deficit hyperactivity disorder [PDF]
, 2011 This study investigated whether methylphenidate is effective in improving response inhibition in children with Attention Deficit Hyperactivity Disorder (ADHD).
Brackenridge, Rachel +3 more
core +1 more source
From clinical application to cognitive enhancement: the example of methylphenidate [PDF]
, 2016 Methylphenidate (MPD) is a central nervous system (CNS) stimulant, which belongs to the phenethylamine group and is mainly used in the treatment of attention deficit hyperactive disorder (ADHD).
Busardo', FRANCESCO PAOLO +4 more
core +1 more source
Differential effects of MDMA and methylphenidate on social cognition [PDF]
, 2014 Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown.
Crockett, Molly J. +5 more
core +1 more source
Nootropics use in the workplace. Psychiatric and ethical aftermath towards the new frontier of bioengineering [PDF]
, 2020 OBJECTIVE: The authors have sought to expound upon and shed a light on the rise of nootropics, which have gradually taken on a more and more relevant role in workplaces and academic settings.
Bersani, G +5 more
core +1 more source